Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration

References

• SingelynFJ, FerrantT, MalisseMF, et al. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous femoral nerve sheath block on rehabilitation after unilateral total-hip arthroplasty. Reg Anesth Pain Med. 2005;30:452–457.16135349
   PubMed Web of Science ®Google Scholar
• MannC, PouzeratteY, BoccaraG, et al. Comparison of intravenous or epidural patient-controlled analgesia in the elderly after major abdominal surgery. Anesthesiology. 2000;92:433–441.10691230
   PubMed Web of Science ®Google Scholar
• BonnerJC, McclymontW. Respiratory arrest in an obstetric patient using remifentanil patient-controlled analgesia. Anaesthesia. 2012;67:538–540.22268797
   PubMed Web of Science ®Google Scholar
• MadejTH, StruninL. Comparison of epidural fentanyl with sufentanil. Analgesia and side effects after a single bolus dose during elective caesarean section. Anaesthesia. 2010;42:1156–1161.
   Web of Science ®Google Scholar
• MarwahR, HassanS, CarvalhoJC, et al. Remifentanil versus fentanyl for intravenous patient-controlled labour analgesia: an observational study. Can J Anasth. 2012;59:246–254.
   PubMed Web of Science ®Google Scholar
• JinHK, SunYJ, KimMJ, et al. Comparison of pain-relieving effects of fentanyl versus ketorolac after eye amputation surgery. Kjo. 2013;27:229–234.23908567
   PubMedGoogle Scholar
• CepedaMS, AlvarezH, MoralesO, et al. Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects. Pain. 2004;107:41–46.14715387
   PubMed Web of Science ®Google Scholar
• FirouzianA, GholipourBA, AlipourA, et al. Ultra-low-dose naloxone as an adjuvant to patient controlled analgesia (PCA) with morphine for postoperative pain relief following lumber discectomy: a double-blind, randomized, placebo-controlled trial. J Neurosurg Anesth. 2016;30:26–31.
   Web of Science ®Google Scholar
• CarrDB, CepedaMS. ‘Simply no difference’ in pain intensity and opioid requirement when ultralow doses of naloxone are added to morphine PCA. Pain. 2004;110:502–503.15275807
   PubMed Web of Science ®Google Scholar
• ZhengJ, HanW, HanXD, et al. Effect of naloxone on intravenous fentanyl patient-controlled analgesia after laparoscopic cholecystectomy. Medicine. 2016;95:e5074.
   PubMed Web of Science ®Google Scholar
• TianH, DongD, SongC, et al. Postoperative intravenous analgesia with fentanyl alone or fentanyl in combination with naloxone, ketamine or dexmedetomidine in elderly patients. Int J Clin Exp Med. 2018;11:1015–1020.
   Web of Science ®Google Scholar
• Chapalain-PargadeS, LavilleI, PaciA, et al. Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery systems. J Pain Symptom Manga. 2006;32:90–97.
   PubMed Web of Science ®Google Scholar
• SelbachS, DiederichWE, FettS, et al. Stability-indicating HPLC assays for the determination of piritramide and droperidol in PCA solution. J Clin Pharm Ther. 2015;36:161–165.
   Web of Science ®Google Scholar
• SattlerA, JageJ, KrämerI. Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine. Pharmazie. 1998;53:386–391.9675768
   PubMed Web of Science ®Google Scholar
• LewinAH, S EF, ZhongD, et al. Caged naloxone: synthesis, characterization, and stability of 3-O-(4,5-dimethoxy-2-nitrophenyl) carboxymethyl naloxone (CNV-NLX). ACS Chem Neurosci. 2018;9:563–567.29154536
   PubMed Web of Science ®Google Scholar
• KistnerC, EnsomMH, DecarieD, et al. Compatibility and stability of morphine sulphate and naloxone hydrochloride in 0.9% sodium chloride for injection. CanJ Hosp Pharm. 2013;66:163–170.23814283
   PubMedGoogle Scholar
• ChenF, XiongH, YangJ, et al. Butorphanol and ketamine combined in infusion solutions for patient-controlled analgesia administration: a long-term stability study. Med Sci Monitor. 2015;21:1138–1145.
   PubMed Web of Science ®Google Scholar
• ChenFC, ZhuJ, LiB, et al. Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems. Drug DesDev Ther. 2016;10:1869–1875.
   PubMed Web of Science ®Google Scholar
• ChenFC, FangBX, LiP, et al. Compatibility of butorphanol and droperidol in0.9% sodium chloride injection. Am J Health Syst Pharm. 2013;70:515–519.23456405
   PubMed Web of Science ®Google Scholar
• PetersonG, MillerK, GallowayJ, et al. Compatibility and stability of fentanyl admixtures in polypropylene syringes. J Clin Pharm Ther. 2010;23:67–72.
   Web of Science ®Google Scholar
• PharmDRMCB. Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags. Int J Pharm Compd. 2005;9:482–484.23925167
   PubMedGoogle Scholar
• MccluskeySV, GranerKK, KempJ, et al. Stability of fentanyl 5 microg/mL diluted with 0.9% sodium chloride injection and stored in polypropylene syringes. Am J Health Syst Pharm. 2009;66:860–862.19386950
   PubMed Web of Science ®Google Scholar
• AndersonC, MackayM. Stability of fentanyl citrate, hydromorphonehydrochloride, ketamine hydrochloride, midazolam, morphine sulfate, and pentobarbital sodium in polypropylene syringes. Pharmacy. 2015;3:379–385.28975923
   PubMedGoogle Scholar
• A LJ, StilesML, WangDP, et al. Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs. Am J Hosp Pharm. 1993;50:714–718.8470692
   PubMedGoogle Scholar
• ChenFC, FangBX, PengL, et al. Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions. Afr J Pharm Pharmacol. 2012;6:2055–2060.
   Google Scholar
• Helin-TanninenM, LehtonenM, NaaranlahtiT, et al. Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine. J Clin PharmTher. 2013;38:104–108.
   Google Scholar
• PanchagnulaR, SharmaP, KhandavilliS, et al. RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation. Farmaco. 2004;59:839–842.15474062
   PubMedGoogle Scholar
• CloutierC, TalianoJ, O’MahonyW, et al. Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: A placebo-controlled, randomized study. Pain Res Manag. 2016;18:75–82.
   Web of Science ®Google Scholar
• Robustelli Della CunaFS, MellaM, MagistraliG, et al. Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration. Am J Health-Syst Pharm. 2001;58:1753–1756.11571819
   PubMed Web of Science ®Google Scholar
• KastangoES, BradshawBD. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health-Syst Pharm. 2004;61:192–1938.
   Web of Science ®Google Scholar